News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
48,196 Results
Type
Article (2123)
Company Profile (7)
Press Release (46065)
Section
Business (20095)
Career Advice (69)
Deals (2845)
Drug Delivery (7)
Drug Development (7521)
Employer Resources (12)
FDA (1126)
Job Trends (1616)
News (28762)
Policy (1590)
Tag
2027 Genetown Standard (1)
Academia (116)
Accelerated approval (10)
ADA (9)
Allergies (23)
Alliances (1275)
ALS (42)
Alzheimer's disease (143)
Antibody-drug conjugate (ADC) (66)
Approvals (1259)
Artificial intelligence (34)
ASCO (50)
Autoimmune disease (49)
Automation (3)
Bankruptcy (9)
Best Places to Work (1547)
BIOSECURE Act (1)
Biosimilars (15)
BioSpace Insights (3)
Biotechnology (3)
Bladder cancer (35)
Brain cancer (4)
Breast cancer (140)
Cancer (792)
Cardiovascular disease (63)
Career advice (64)
Career pathing (2)
CAR-T (21)
CDC (1)
CDMO (6)
Celiac Disease (1)
Cell therapy (53)
Cervical cancer (12)
Clinical research (7731)
Collaboration (105)
Company closure (1)
Compensation (250)
Complete response letters (6)
COVID-19 (217)
CRISPR (4)
C-suite (40)
Cystic fibrosis (11)
Data (1463)
Depression (15)
Dermatology (28)
Diabetes (69)
Diagnostics (580)
Digital health (5)
Diversity, equity & inclusion (3)
Drug discovery (16)
Drug pricing (6)
Drug shortages (3)
Duchenne muscular dystrophy (36)
Earnings (19050)
Employer branding (2)
Employer resources (10)
Events (4360)
Executive appointments (35)
FDA (1723)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (105)
Gene editing (8)
Generative AI (3)
Gene therapy (51)
GLP-1 (142)
Government (288)
Guidances (217)
Healthcare (1599)
Hematology (15)
HIV (24)
Huntington's disease (4)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (24)
Immunology and inflammation (35)
Immuno-oncology (6)
Indications (34)
Infectious disease (255)
Inflammatory bowel disease (26)
Inflation Reduction Act (1)
Influenza (16)
Intellectual property (13)
Interviews (12)
IPO (2084)
IRA (2)
Job creations (147)
Job search strategy (48)
JPM (1)
Kidney cancer (4)
Labor market (21)
Layoffs (49)
Leadership (1)
Legal (184)
Licensing (1)
Liver cancer (8)
Longevity (4)
Lung cancer (155)
Lymphoma (82)
Machine learning (3)
Management (3)
Manufacturing (52)
Marketing (1)
MASH (51)
Medical device (1098)
Medtech (1119)
Mergers & acquisitions (830)
Metabolic disorders (254)
mRNA (17)
Multiple sclerosis (56)
NASH (4)
Neurodegenerative disease (44)
Neuropsychiatric disorders (13)
Neuroscience (342)
NextGen: Class of 2026 (309)
Non-profit (243)
Now hiring (2)
Obesity (127)
Opinion (8)
Ovarian cancer (28)
Pain (36)
Pancreatic cancer (23)
Parkinson's disease (25)
Partnered (1)
Patents (14)
Patient recruitment (47)
Peanut (13)
People (1173)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (1490)
Phase 2 (3162)
Phase 3 (3588)
Pipeline (2234)
Policy (13)
Postmarket research (324)
Preclinical (344)
Press Release (2)
Prostate cancer (41)
Psychedelics (5)
Radiopharmaceuticals (26)
Rare diseases (119)
Real estate (193)
Recruiting (7)
Regulatory (1660)
Reports (6)
Research institute (112)
Resumes & cover letters (7)
Rett syndrome (1)
RNA editing (1)
RSV (9)
Schizophrenia (18)
Series A (9)
Series B (10)
Sickle cell disease (14)
Special edition (4)
Spinal muscular atrophy (9)
Sponsored (3)
Startups (75)
Stomach cancer (2)
Supply chain (6)
Tariffs (2)
The Weekly (4)
Vaccines (83)
Venture capital (13)
Weight loss (71)
Women's health (11)
Worklife (2)
Date
Last 7 days (56)
Last 30 days (214)
Last 365 days (3626)
2026 (2530)
2025 (3470)
2024 (3595)
2023 (3727)
2022 (4252)
2021 (4195)
2020 (3808)
2019 (3117)
2018 (2580)
2017 (2075)
2016 (1542)
2015 (1950)
2014 (1274)
2013 (866)
2012 (1118)
2011 (1349)
2010 (1194)
Location
Africa (40)
Alabama (20)
Arizona (36)
Asia (2883)
Australia (298)
California (1685)
Canada (365)
China (198)
Colorado (72)
Connecticut (63)
Delaware (89)
Europe (6791)
Florida (200)
Georgia (55)
Idaho (2)
Illinois (125)
India (5)
Indiana (112)
Japan (95)
Kansas (13)
Kentucky (6)
Louisiana (18)
Maine (13)
Maryland (202)
Massachusetts (1165)
Michigan (39)
Minnesota (91)
Mississippi (1)
Missouri (14)
Montana (2)
Nevada (20)
New Hampshire (7)
New Jersey (666)
New York (490)
North Carolina (183)
Northern California (996)
Ohio (42)
Oklahoma (1)
Oregon (1)
Pennsylvania (314)
Puerto Rico (2)
Rhode Island (1)
South America (69)
South Carolina (7)
Southern California (596)
Tennessee (19)
Texas (193)
United States (5956)
Utah (43)
Virginia (19)
Washington D.C. (4)
Washington State (98)
West Virginia (1)
Wisconsin (7)
48,196 Results for "48".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Theralase(R) Closes C$4.8 Million Offering
May 20, 2026
·
8 min read
Press Releases
RapidPulse Secures Oversubscribed $48M Series B Financing to Advance Clinical Development of Next-Generation Stroke Aspiration Technology
July 16, 2026
·
6 min read
Government
Despite mRNA Vaccine Pullback, HHS Awards $48M for Kernal’s mRNA CAR T Program
The $48 million award, granted through the Advanced Research Projects Agency for Health, will help Kernal take its in vivo mRNA-encoded CAR T therapy forward.
October 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Vizgen Announces $48 Million Financing
January 8, 2026
·
2 min read
Press Releases
Kanvas Biosciences Secures $48M Series A to Deliver Novel Microbiome Therapeutics to Cancer Patients
May 6, 2026
·
5 min read
Press Releases
Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study
June 29, 2026
·
8 min read
Press Releases
D&D Pharmatech Announces Positive 48-Week Histology Results for Zabopegdutide (DD01), Demonstrating Statistically Significant Fibrosis Improvement and MASH Resolution
May 27, 2026
·
6 min read
Press Releases
Ascletis Selects for Clinical Development a Fixed-Dose Combination of First-in-Class Oral Small Molecule GIPR Agonist, ASC48, and Oral Small Molecule GLP-1R Agonist, ASC30
July 15, 2026
·
4 min read
Press Releases
Pemvidutide Demonstrates Significant Metabolic Improvements in Patients with MASH in New 48‑Week IMPACT Phase 2b Data Presented at EASL 2026
May 28, 2026
·
7 min read
Press Releases
Generic Drugs Market Enters a Transformative Era Where Innovation and Accessibility Converge to Shape a USD 762.48 Bn Future by 2035
May 5, 2026
·
1 min read
1 of 4,820
Next
